HomePLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
$2.19
Makalipas ang Oras ng Trabaho:(2.66%)+0.058
$2.25
Sarado: Abr 1, 4:35:01 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$2.19
Sakop ng araw
$2.17 - $2.26
Sakop ng taon
$1.32 - $3.19
Market cap
176.45M USD
Average na Volume
1.22M
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 9.12M | -49.93% |
Gastos sa pagpapatakbo | -9.73M | -85.01% |
Net na kita | -5.50M | -184.76% |
Net profit margin | -60.34 | -269.26% |
Kita sa bawat share | — | — |
EBITDA | -4.27M | -156.62% |
Aktuwal na % ng binabayarang buwis | -15.24% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 30.27M | -13.08% |
Kabuuang asset | 82.35M | 12.16% |
Kabuuang sagutin | 34.12M | 12.94% |
Kabuuang equity | 48.23M | — |
Natitirang share | 80.57M | — |
Presyo para makapag-book | 3.64 | — |
Return on assets | -14.15% | — |
Return on capital | -19.80% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -5.50M | -184.76% |
Cash mula sa mga operasyon | 2.03M | -49.14% |
Cash mula sa pag-invest | -1.11M | 92.74% |
Cash mula sa financing | 146.00K | -95.97% |
Net change in cash | 1.03M | 113.51% |
Malayang cash flow | 2.88M | 72.67% |
Tungkol
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Itinatag
1993
Headquarters
Website
Mga Empleyado
226
